- Previous Close
65.00 - Open
66.40 - Bid 66.90 x --
- Ask 67.40 x --
- Day's Range
64.70 - 67.50 - 52 Week Range
42.15 - 109.80 - Volume
23,558 - Avg. Volume
68,131 - Market Cap (intraday)
5.875B - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
197.06 - EPS (TTM)
0.34 - Earnings Date Feb 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 9, 2024
- 1y Target Est
60.68
Aker BioMarine AS engages in harvesting krill and supplies krill-derived products worldwide. It operates through two segments, Ingredients and Brands. The Ingredients segment is involved in the offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products for nutraceutical, pet food, and aquaculture industries. The Brands segment produces and distributes private label vitamins and supplements to retailers. The company provides Superba, a krill oil; QRILL Aqua, an ingredient for formulated feeds; FloraMarine, a plant-based marine source of DHA omega-3 from algae; and QRILL Pet, a functional marine ingredient for pets. It also offers LYSOVETA, a supplement product for brain health; and Understory, a protein peptides product. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles plastic products. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
www.akerbiomarine.com373
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AKBM.OL
View MorePerformance Overview: AKBM.OL
Trailing total returns as of 1/9/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AKBM.OL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AKBM.OL
View MoreValuation Measures
Market Cap
5.70B
Enterprise Value
7.23B
Trailing P/E
191.68
Forward P/E
38.31
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.48
Price/Book (mrq)
2.66
Enterprise Value/Revenue
1.90
Enterprise Value/EBITDA
13.68
Financial Highlights
Profitability and Income Statement
Profit Margin
61.59%
Return on Assets (ttm)
0.47%
Return on Equity (ttm)
0.95%
Revenue (ttm)
334.8M
Net Income Avi to Common (ttm)
2.6M
Diluted EPS (ttm)
0.34
Balance Sheet and Cash Flow
Total Cash (mrq)
14.9M
Total Debt/Equity (mrq)
79.18%
Levered Free Cash Flow (ttm)
92.12M